4//SEC Filing
Avoro Capital Advisors LLC 4
Accession 0001415889-25-017406
CIK 0001422142other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:51 PM ET
Size
17.6 KB
Accession
0001415889-25-017406
Insider Transaction Report
Form 4
Aghazadeh Behzad
Director10% OwnerOther
Transactions
- Award
Stock Option (right to buy)
2025-06-12+40,006→ 40,006 totalExercise: $2.04Exp: 2035-06-12→ Common Stock (40,006 underlying)
Avoro Ventures LLC
Director10% OwnerOther
Transactions
- Award
Stock Option (right to buy)
2025-06-12+40,006→ 40,006 totalExercise: $2.04Exp: 2035-06-12→ Common Stock (40,006 underlying)
Avoro Capital Advisors LLC
Director10% OwnerOther
Transactions
- Award
Stock Option (right to buy)
2025-06-12+40,006→ 40,006 totalExercise: $2.04Exp: 2035-06-12→ Common Stock (40,006 underlying)
Footnotes (3)
- [F1]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 12, 2025.
- [F2]This Form 4 is filed by Avoro Capital Advisors LLC, a Delaware limited liability company ("Avoro Capital Advisors"), Avoro Ventures LLC, a Delaware limited liability company ("Avoro Ventures") and Behzad Aghazadeh ("Dr. Aghazadeh", and together with Avoro Capital Advisors and Avoro Ventures, the "Reporting Persons"). Dr. Aghazadeh serves as the portfolio manager and controlling person of Avoro Capital Advisors and Avoro Ventures LLC.
- [F3]The filing of this statement shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.
Documents
Issuer
Whitehawk Therapeutics, Inc.
CIK 0001422142
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001633313
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 4:51 PM ET
- Size
- 17.6 KB